Metraipolis › archive › dc_db94cf7ea248
Impact of genotyping (PTPN2, rs2542151) and (MBOAT7, rs641738) in prediction of fibrosis in Metabolic dysfunction- associated steatotic liver disease' patients — Europe PMC PMID:41019340
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41019340
- DOI
- 10.3389/fendo.2025.1615162
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T00:42:28.111Z
- SHA-256 of the archived text
343e497e706603dd789f1d705b8f0dd9873dd312d73adf2e462a3aaee06adc53- Stable URL of this page
https://metraipolis.com/documento/dc_db94cf7ea248
How to cite
Impact of genotyping (PTPN2, rs2542151) and (MBOAT7, rs641738) in prediction of fibrosis in Metabolic dysfunction- associated steatotic liver disease' patients — Europe PMC PMID:41019340 — Europe PMC (en), https://europepmc.org/article/MED/41019340 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db94cf7ea248 (Metraipolis archive dc_db94cf7ea248, sha256 343e497e706603dd789f1d705b8f0dd9873dd312d73adf2e462a3aaee06adc53)
BibTeX
@misc{dcdb94cf7ea248,
title = {Impact of genotyping (PTPN2, rs2542151) and (MBOAT7, rs641738) in prediction of fibrosis in Metabolic dysfunction- associated steatotic liver disease' patients — Europe PMC PMID:41019340},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41019340},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db94cf7ea248; sha256 343e497e706603dd789f1d705b8f0dd9873dd312d73adf2e462a3aaee06adc53},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41019340. Agents can read the archived copy with the MCP tool read_document.